dr. rudin on the design of the keynote-604 trial in es-sclc
Published 4 years ago • 91 plays • Length 1:02Download video MP4
Download video MP3
Similar videos
-
5:02
researcher comment: the keynote-604 trial | charles rudin
-
2:47
charles rudin, md, phd, shares outcomes of the keynote 604 study to investigating keytruda and chemo
-
0:53
charles rudin, md, phd, discusses the keynote-604 study and the role of keytruda in es-sclc
-
4:20
keynote-604: pembrolizumab plus etoposide and platinum as a first-line therapy for extensive-sta...
-
4:57
chemoimmunotherapy for es sclc: caspian trial
-
0:46
charles rudin, md, phd, shares the take home message regarding keynote-604 for lung cancer treatment
-
0:54
dr. rudin on caveats of the keynote-021 in patients with nsclc
-
9:39
extreme optics and imaging (extreme)
-
32:12
immunotherapy in non-small cell lung cancer (nsclc): front line therapy
-
27:08
immunotherapy advances in small cell lung cancer
-
0:38
the importance of designing a welcoming and comfortable environment for patients
-
1:36
dr. rudin on expansion of immunotherapy in lung cancer
-
1:15
dr. rudin discusses the success of immunotherapy in sclc
-
2:17
small cell lung cancer: future directions in care
-
1:41
dr. rudin on rova-t in patients with small cell lung cancer
-
3:08
developments in treatment for es-sclc over the last 5 years | paul bunn, md | esmo22 colorado
-
8:19
keynote trial data: pembrolizumab’s role in nsclc
-
1:20
dr. charles rudin: immunotherapy for small cell lung cancer
-
24:51
what is the future of endoscopy - ralf wagner, m.d.
-
6:32
keynote trials show pembrolizumab benefited patients with advanced small cell lung cancer
-
1:19
dr. sio on optimal radiation therapy dose in locally advanced nsclc
-
30:14
extensive stage small cell lung cancer